
1. cell rep. 2013 nov 27;5(4):886-94. doi: 10.1016/j.celrep.2013.09.040. epub 2013
oct 31.

the bet family proteins targets moloney murine leukemia virus integration near
transcription start sites.

de rijck j(1), de kogel c, demeulemeester j, vets s, el ashkar s, malani n,
bushman fd, landuyt b, husson sj, busschots k, gijsbers r, debyser z.

author information: 
(1)laboratory molecular virology gene therapy, ku leuven, 3000 leuven,
belgium.

a hallmark retroviral replication integration viral genome host
cell dna. characteristic makes retrovirus-based vectors attractive delivery 
vehicles gene therapy. however, adverse events gene therapeutic trials,
caused activation proto-oncogenes due murine leukemia virus
(mlv)-derived vector integration, hamper application. here, show that
bromodomain extraterminal (bet) proteins (brd2, brd3, brd4) mlv
integrase specifically interact colocalize within nucleus cell.
inhibition bet proteins' chromatin interaction via specific bromodomain
inhibitors blocks mlv virus replication integration step. mlv integration 
site distribution parallels chromatin binding profile bet proteins, and
expression artificial fusion protein bet integrase binding domain
with chromatin interaction domain lentiviral targeting factor
ledgf/p75 retargets mlv integration away transcription start sites 
the body actively transcribed genes, conforming hiv integration
pattern. together, data validate bet proteins mlv integration targeting 
factors.

copyright Â© 2013 authors. published elsevier inc. rights reserved.

doi: 10.1016/j.celrep.2013.09.040 
pmcid: pmc4197836
pmid: 24183673  [indexed medline]

